WilliamBlumMD

Oncology • Atlanta, GA

Professor, Hematology and Oncology and Director, Acute Leukemia Program; Winship Cancer Institute of Emory University

Join to view full profile

Dr. Blum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blum's full profile

Already have an account?

Office
1365 Clifton Rd NE
Bldg C
Atlanta, GA 30322
Phone+1 404-778-7408

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2000 - 2003
University of Virginia Medical CenterResidency, Internal Medicine, 1997 - 2000
Medical College of Georgia at Augusta UniversityClass of 1997

Certifications & Licensure

GA State Medical License 2017 - 2026
OH State Medical License 2003 - 2019
VA State Medical License 1997 - 2002
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2006 Mar 01
Terminated
Phase 1
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. Start of enrollment: 2007 Apr 01
Completed
Phase 1
Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2007 May 01
Completed
Phase 2
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2008 Apr 01
Completed
Phase 1
Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Jun 01
Completed
Phase 1
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2009 Jan 01
Unknown status
Phase 2
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
Completed
Phase 1
SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia Start of enrollment: 2014 Sep 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort op...
Jorge E Cortes, Gail J Roboz, Maria R Baer, Brian A Jonas, Gary J Schiller
Journal of Hematology & Oncology. 2025-01-16
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies.
Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, Daelynn R Buelow, Shelley Orwick
Leukemia. 2025-01-13
2 citations
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.
Fieke W Hoff, William G Blum, Ying Huang, Rina Li Welkie, Ronan T Swords
Blood Advances. 2024-10-22

Abstracts/Posters

Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E...
William Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
William Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Prevalence of Inherited Cancer Predisposition Mutations in a Cohort of Older AML Patients Enrolled on the Beat AML Master Trial
William Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023
COVID-19 Timeline Exposes Falsehood of US and US Lackey Australian Anti-China Blame GameMay 21st, 2020
Per Capita Covid-19 Deaths in Anglosphere 5-Eyes Intelligence-Sharing Nations Correlate with Neoliberal GreedMay 17th, 2020